| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/20/1999 | EP0891352A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891351A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891350A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891349A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891344A1 Alpha 1-adrenergic receptor antagonists |
| 01/20/1999 | EP0891343A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891332A1 6-phenylpyridyl-2-amine derivatives |
| 01/20/1999 | EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891326A1 Novel vitamin d analogues |
| 01/20/1999 | EP0891325A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 01/20/1999 | EP0891322A1 Dimethyl-substituted cyclohexane diene derivatives |
| 01/20/1999 | EP0693053B1 Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0630245B1 Protein kinase c inhibitor |
| 01/20/1999 | CN1205707A Sugar-substituted 2-azetidinones useful as hypocholesterolemic gents |
| 01/20/1999 | CN1205704A 2,7-substituted octahydro-pyrrolo (1,2-A) pyrazine derivatives |
| 01/20/1999 | CN1205701A Trans apovincaminic acid ester derivatives as drugs |
| 01/20/1999 | CN1205694A Quinazoline derivatives |
| 01/20/1999 | CN1205335A Tricyclic diazepine vasopression antagonists |
| 01/20/1999 | CN1205328A Sulfonylaminocarboxylic acids |
| 01/20/1999 | CN1205210A Chinese medicine compositions and preparation for prevention and treatment of cerebrovascular atherosclerosis and cancer |
| 01/20/1999 | CN1205205A Pyrazolopyridine compound and processes for preparation thereof |
| 01/19/1999 | US5861496 Nucleic acid and amino acid sequences of a novel squalene epoxidase and to the use of these sequences in the diagnosis, prevention, and treatment of diseases such as hypercholesterolemia and atherosclerosis. |
| 01/19/1999 | US5861484 Treatment of psoriasis, rheumatoid arthritis, hemangiomas, angiofibromas, diabetic retinopathy, neovascular glaucoma,and other vegf-induced pathological angiogenesis and vascular permeability conditions, such as tumor vascularization |
| 01/19/1999 | US5861436 Inhibitors of the relese of tumor necrosis factor |
| 01/19/1999 | US5861434 Compositions containing L-carnitine or an acyl L-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders |
| 01/19/1999 | US5861426 Nitro esters of aromatic compounds with amide or ester groups |
| 01/19/1999 | US5861404 2,9-disubstituted purin-6-ones |
| 01/19/1999 | US5861402 1,4-dihydropyridine compounds |
| 01/19/1999 | US5861401 Treatment of congestive heart failure |
| 01/19/1999 | US5861396 Purin-6-one derivatives |
| 01/19/1999 | US5861394 Use of N-substituted phenothiazines |
| 01/19/1999 | US5861393 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 01/19/1999 | US5861385 Drug intermediates for compounds that lower cholesterol or treat hyperlipoproteinemia formed by reduction of acid or ester compounds with hydroxy or ether groups |
| 01/19/1999 | US5861380 Oxadiazole, thiadiazole and triazole peptoids as inhibitors of human neutrophil elastase; adult respiratory distress syndrome; antiarthritic,-inflammatory,-ischemic,-tumor and -carcinogenic agents and other hne-mediated conditions |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861281 Lacc |
| 01/19/1999 | US5861276 CDNAS encoding murine antibody against human plasma apolipoprotein B-100 |
| 01/19/1999 | US5861173 Sustained release tablets with press coating on core of gel |
| 01/19/1999 | CA2166902C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 01/19/1999 | CA2061607C 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/16/1999 | CA2237784A1 Novel compounds |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
| 01/14/1999 | WO1999001472A1 Cyclic azapeptides with angiogenic effect |
| 01/14/1999 | WO1999001454A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 01/14/1999 | WO1999001452A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | WO1999001439A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | WO1999001438A1 New compounds |
| 01/14/1999 | WO1999001437A1 Compounds |
| 01/14/1999 | WO1999001435A1 (1h-imidazol-4-yl)piperidine derivatives, preparation and application in therapy |
| 01/14/1999 | WO1999001426A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001421A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | WO1999001151A1 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity |
| 01/14/1999 | WO1999001136A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001135A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 01/14/1999 | WO1999001131A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001130A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001128A1 Certain diarylimidazole derivatives; a new class of npy specific ligands |
| 01/14/1999 | WO1999001127A1 Compounds and methods |
| 01/14/1999 | WO1999001118A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 01/14/1999 | WO1998038986A3 Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections |
| 01/14/1999 | WO1998035020A3 Methods for modulating hematopoiesis and vascular growth |
| 01/14/1999 | CA2297181A1 Cyclic azapeptides |
| 01/14/1999 | CA2296014A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | CA2295762A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | CA2295294A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | CA2295228A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294898A1 Certain diarylimidazole derivatives; a new class of npy specific ligands |
| 01/14/1999 | CA2294882A1 Compounds |
| 01/14/1999 | CA2294824A1 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity |
| 01/14/1999 | CA2294770A1 Compounds and methods |
| 01/14/1999 | CA2294746A1 New compounds |
| 01/14/1999 | CA2294524A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294522A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294117A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 01/14/1999 | CA2290509A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0889972A1 Diagnostic method and apparatus |
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |
| 01/13/1999 | EP0889906A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 01/13/1999 | EP0889900A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 01/13/1999 | EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin |
| 01/13/1999 | EP0889891A1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
| 01/13/1999 | EP0889888A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889887A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889884A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation |
| 01/13/1999 | EP0889880A1 Eprosartan dihydrate and a process for its production and formulation |
| 01/13/1999 | EP0889876A1 Meta-substituted phenylene sulphonamide derivatives |
| 01/13/1999 | EP0889875A1 Cyclopropyl alkanoic acid derivatives |
| 01/13/1999 | EP0889726A1 Novel cycloalkyl substituted imidazoles |
| 01/13/1999 | EP0889690A1 Antibiotic cocktail and method of use |
| 01/13/1999 | EP0757670B1 Benzamide derivatives as vasopressin antagonists |
| 01/13/1999 | EP0731787B1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine |
| 01/13/1999 | CN1205010A Isoxazolidine derivatives |
| 01/13/1999 | CN1205009A Pyrazolopyrimidines type compound |
| 01/13/1999 | CN1205006A Substituted tetracyclic tetrahydrofuran derivatives |